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ABSTRACT OF THE THESIS
DNA APTAMER CONFIRMATION AND UTILIZATION FOR THE CYANOTOXIN,
CYLINDROSPERMOPSIN
by
Diane M. Catlin
Florida International University, 2016
Miami, Florida
Professor John Berry, Major Professor
Cyanotoxins are posing an increasing threat to the health of humans and
wildlife. Cylindrospermopsin is a cyanotoxin that occurs in warm climates and is
harmful when ingested. The toxic effects of CYN can affect multiple organ systems.
The effects, coupled with the evidence of a mass contamination of a water supply in
Australia, prove that CYN needs to be investigated further.
Aptamers have become a desirable method for detection of CYN as a result of an
aptamer’s high specificity and the ability to scale up experiments. Aptamers have been
designed to bind with a variety of targets, including cyanotoxins. An aptamer for CYN
was identified by Elshafey et al.
This study aims to confirm the binding of the aptamer to CYN and the selectivity
of the aptamer using fluorescent biosensing and circular dichroism. Aptamer affinity
capture was used to investigate the possibility of a real world application of the aptamer.

v

TABLE OF CONTENTS
CHAPTER

PAGE

1. Introduction ......................................................................................................................1
1.1 Cyanobacteria ............................................................................................................1
1.1.1 Cyanobacterial toxins ....................................................................................2
1.2 Cylindrospermopsin .................................................................................................3
1.3 DNA Aptamers .........................................................................................................5
1.4 Circular Dichroism....................................................................................................9
1.5 Fluorescent Biosensing ...........................................................................................10
1.6 Aptamer Affinity Chromatography.........................................................................10
1.7 Specific Aims ..........................................................................................................13
2. Materials ........................................................................................................................13
2.1 Purification of CYN ................................................................................................13
2.2 Fluorescent Biosensing ...........................................................................................14
2.3 Circular Dichroism..................................................................................................15
2.4 Aptamer Affinity Capture .......................................................................................15
2.5 Urea PAGE Gel.......................................................................................................16
3. Experimental ..................................................................................................................16
3.1 Purification of CYN ................................................................................................16
3.1.1 Pretreatment of Culture Medium and Biomass ..............................................17
3.1.2 Extraction of CYN from Culture Biomass.....................................................17
3.1.3 Extraction of CYN from Culture Medium .....................................................18
3.1.4 HPLC Purification .........................................................................................19
3.2 Fluorescent Biosensing ...........................................................................................20
3.2.1 Fluorimeter.....................................................................................................20
3.2.2 Tecan Plate Reader ........................................................................................20
3.3 Circular Dichroism..................................................................................................21
3.4 Aptamer Affinity Capture .......................................................................................22
3.4.1 Magnetic Bead Activation .............................................................................22
3.4.2 CYN Capture .................................................................................................23
3.4.3 HPLC of AAC Samples .................................................................................23
3.5 Urea PAGE Gel.......................................................................................................24
3.5.1 Gel Preparation ..............................................................................................24
3.5.2 Gel Samples ...................................................................................................24
3.5.3 Running and Imaging the Gel ........................................................................25
4. Results and Discussion ..................................................................................................25
4.1 Fluorescent Biosensing ...........................................................................................25
4.2 Circular Dichroism..................................................................................................31
4.3 Aptamer Affinity Capture .......................................................................................32
4.4 Urea PAGE Gel.......................................................................................................34
5. Conclusions ....................................................................................................................34

vi

LIST OF REFERENCES ...................................................................................................37

vii

LIST OF TABLES
TABLE

PAGE

1. Advantages and Disadvantages of Antibodies in Detecting Target Molecules ..............5
2. Advantages and Disadvantages of Aptamers in Detecting Target Molecules ................6
3. Applications of aptamers in the analysis of the target molecules .................................12
4. Time program for HPLC purification of CYN .............................................................19
5. Time program for detection of CYN ............................................................................24

viii

LIST OF FIGURES
FIGURE

PAGE

1. Cylindrospermopsin structure .........................................................................................3
2. Fluorescent spectrum of (A) Binding buffer (BB), ......................................................25
(B) CYN in BB, (C) Aptamer in BB, (D) Aptamer
in BB (top) 100 uM CYN and Aptamer in BB
(middle) and 500 uM CYN and Aptamer in BB (bottom)
3. Fluorescence spectrum of Aptamer in BB and after ....................................................26
the addition of 10 uM CYN (10 uM), 25 uM CYN
(25 uM), 50 uM CYN (50 uM), 75 uM CYN (75 uM),
and 100 uM CYN (100 uM).
4. Fluorescent spectrum of aptamer after the addition .....................................................26
100 uM Microcystin-LR (MC-LR), 100 uM BMAA
(BMAA), and 100 uM CYN (CYN)
5. Percent Gain of CYN with five different fluorescent probes ......................................27
6. Percent Gain of CYN using QuantiFluor dsDNA probe ..............................................27
7. Reproducibility of Percent Gain of CYN using QuantiFluor dsDNA probe ................28
8. Reproducibility of Percent Gain of MC-LR using QuantiFluor dsDNA probe ............28
9. Reproducibility of Percent Gain of BMAA using QuantiFluor dsDNA probe ............29
10. Comparison of Percent Gain of the three toxins with QuantiFluor dsDNA probe .....29
11. CD spectrum of (A) 1 uM aptamer before and after ..................................................31
the addition of 2 uM CYN performed by Elshafey
et al. [33] and (B) 1 uM aptamer before and after the
addition of 2 uM CYN
12. Chromatogram of (A) supernatent after incubation ...................................................32
with beads, (B) 75 uM CYN standard, (C) supernatant
after elution with Milli-Q® water, (D) supernatant after
wash with BB

ix

13. (A) Urea PAGE Gel of DNA ladder (1), Aptamer (2), ..............................................34
Aptamer and CYN (3), Aptamer and MC-LR (4),
Aptamer and BMAA (5), and DNA Ladder (6), (B)
inverse of gel (A)

x

ACRONYMS AND ABBREVIATIONS
AAC

Aptamer Affinity Capture

ACN

Acetonitrile

APS

Ammonium persulfate

BB

Binding buffer

BMAA

β-Methylamino-L-alanine

CYN

Cylindrospermopsin

EDC
FA

N-Ethyl-N'-(3-dimethylaminopropyl)
carbodiimide hydrochloride
Formic Acid

HPLC

High Performance Liquid Chromatography

MC-LR

Microcystin-LR

MeOH

Methanol

MES
Milli-Q®

2-(N-Morpholino)ethanesulfonic acid
hydrate
Ultra-pure water

PAGE

Polyacrylamide gel electrophoresis

SPE

Solid phase extraction

TEMED

N,N,N’,N’,-Tetramethylethylenediamine

TFA

Trifluoroacetic acid

UFLC

Ultra Fast Liquid Chromatography

UV

Ultra violet

xi

1. Introduction
1.1 Cyanobacteria
Cyanobacteria are prokaryotic organisms that synthesize chlorophyll a through
photosynthesis. Most of these organisms are aquatic, using water as the electron donor
for oxygen production. Though aquatic in nature, cyanobacteria exist in a wide range of
environments. Cyanobacteria thrive particularly in warmer environments and can
withstand high salt concentrations. Ultra-violet (UV) conditions vary greatly in
environments inhabited by cyanobacteria. These organisms can utilize UV light even in
low light density conditions which makes cyanobacteria resilient organisms [1].
Cyanobacteria are often called “blue-green algae” because of their production of
blue pigments [1]. Blue-green algae can form in blooms in aquatic environments,
forming a covering over bodies of water. The algal blooms can affect the environments
below the blooms and main water supplies by decreasing the amount of sunlight that can
reach photosynthetic species below the surface. The amount of dissolved oxygen in the
water decreases because the bloom does not allow for a flow of oxygen from the surface.
The blooms can hinder the filtering and purification of water that is used to supply homes
and businesses. Another issue these bloom-forming species of cyanobacteria pose is that
many of them are considered to be toxin producing. These species produce
cyanobacterial toxins that can be harmful to the environment and other species including
humans through the food chains and biomagnification [2].
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1.1.1 Cyanobacterial Toxins
Cyanobacterial toxins or cyanotoxins are an increasing problem in aquatic
environments. Cyanotoxins are produced by cyanobacteria and can be released in to the
water systems where there is presence of blue-green algae. There are 40 different species
of cyanobacteria that are believed to produce some form of cyanotoxin. These toxins are
categorized in to four groups. The four groups are: hepatotoxins, neurotoxins, endotoxins
and general cytotoxins. The general cytotoxins do not have a targeted system as the other
groups do. The general cytotoxins can affect one or multiple organs making it more
difficult to treat an exposure [2] .
Cyanotoxins not only affect freshwater and marine organisms, they also pose a
risk to humans. These toxins reach humans through contamination of drinking water or
where humans come into contact with water such as lakes and oceans [3-5]. Water
sources are an optimal source for algal bloom growth as a result of pollution from
pharmaceuticals and fertilizers. The pollution proves an abundance of nutrients that
support algal blooms. Cyanotoxins can persist in water even after the bloom has died off.
The persistence results in bioaccumulation which can lead to biomagnification [6].
Biomagnification is the process of toxins being transferred in increasing concentrations
from organisms lower on the food chain to an organism higher on the food chain.
Animals can have high concentrations of toxins in their system from ingesting their food
source. Animals can also become exposed to these toxins by their water intake. Animals
drink from water sources that are untreated and unfiltered. Humans are less likely to
become exposed to cyanotoxins through their water supply if they have access to filtered
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and treated drinking water but contaminated water sources that are used for recreational
purposes such as lakes and oceans can lead to exposure. [2]
Contamination of water supplies had caused a growing need for the improvement
of detection methods for toxins [6]. Since the toxins can have toxicity levels detrimental
to human health, it is important to determine the quality of the water being used by both
humans and wildlife. Detection of cyanotoxins has been performed using a multitude of
methods. High performance liquid chromatography (HPLC), liquid chromatographymass spectrometry (LCMS), mouse bioassay, protein phosphatase bioassay, and enzymelinked immunosorbent assay (ELISA) have all been used to detect cyanotoxins. These
methods have often been used as a tool in determining safe drinking levels of toxins in
water [7].
1.2 Cylindrospermopsin
The toxin investigated in this work was cylindrospermopsin (CYN).
Cylindrospermopsin is a cyanotoxin produced by multiple species of cyanobacteria.
The toxin is an alkaloid with a cyclic guanidine group. CYN is a water soluble molecule
making it easy to contaminate water systems.

Figure 1. Cylindrospermopsin structure [8]
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It was first reported as having toxic effects in a study done in Australia in the
1980s. Hundreds of children were brought to hospitals in Australia with gastrointestinal
symptoms. These symptoms were linked to blooms of Cylindrospermopsis raciborskii in
the water supply. The incident was the first to show that CYN can affect human health
[9]. Cylindrospermopsin is known to affect the liver, heart, gastrointestinal tract and has
also been studied as having genotoxic effects [10]. It acts as a protein synthesis inhibitor
but the mechanism is unknown. The protein synthesis inhibition causes many of the
symptoms of this toxin [11-13]. Cylindrospermopsin has been reported in areas all over
the world with evidence of algal blooms in those areas [14-15]. The abundance of the
algal blooms and the toxic effects are what make CYN an important topic of research.
High performance liquid chromatography (HPLC) and liquid-chromatography
mass-spectrometry ((HP)LC-MS) have been the primary methods utilized for CYN
detection. HPLC and (HP)LC-MS have allowed for accurate detection but there is
difficulty distinguishing between chiral molecules and molecules with similar masses.
[16] The instruments required for these analyses are expensive and require a high level
of sample purity. [16-17] Enzyme-linked immunosorbent assay, ELISA, has been used
in the analysis of CYN but is also an expensive analytical tool [18]. The ELISA method
uses antibodies to detect and quantify the presence of CYN. Antibodies have both
advantages and disadvantages to their use as seen in Table 1. Aptamers are a new and
emerging technique that address the disadvantages of antibodies and provide an
inexpensive alternative.
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Table 1. Advantages and Disadvantages of Antibodies in Detecting Target Molecules
[19]
Advantages

Disadvantages

- Pharmacokinetic and other systemic
properties of antibodies are often
sufficient to support product
development
- Large size prevents renal filtration
and together with binding to neonatal
Fc receptors can give extended
circulating half-lives
- Not susceptible to nuclease
degradation
- Antibody technologies are widely
distributed because the early
intellectual property either never
existed or has expired

- Antibodies are produced biologically in a
process that is difficult to scale up without
affecting product characteristics -Viral or
bacterial contamination of manufacturing
process can affect product quality
- Often immunogenic
- Large size limits bioavailability or
prevents access to many biological
compartments
- Limited ability to utilize negative selection
pressure or to select against cell-surface
targets not available in functional
recombinant form
- Susceptible to irreversible denaturation;
limited shelf life
- Chemistries required for the attachment of
conjugation partners are stochastic and lead
to product mixtures and reduced activity

1.3 DNA Aptamers
An aptamer is a strand of nucleic acids that when folded into its three-dimensional
structure binds to a target molecule. The use of an aptamer in an analytical method to test
biological samples not only allows for detection of the toxin, but also for accurate
quantification [20-21]. The use of aptamers has advantages over other analytical
methods such as ELISA. Aptamers, as nucleic acids, are more chemically stable than
antibodies with comparable specificity. They can be selected for different types of
molecules such as toxins and proteins and can also be produced in large quantities with
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high purity [22-24]. These advantages make aptamers an attractive addition to analytical
methods of analysis. Aptamer-based methods, like any analytical method, do have
disadvantages (Table 2), but the disadvantages can be addressed to maximize the
effectiveness of the aptamers.
Table 2. Advantages and Disadvantages of Aptamers in Detecting Target Molecules [19]
Advantages

Disadvantages

- Aptamers are produced chemically in
a readily scalable process
- Chemical production process is not
prone to viral or bacterial
contamination
- Non-immunogenic
- Smaller size allows more efficient
entry into biological compartments
- Able to select for and against
specific targets and to select against
cell-surface targets
- Can usually be reversibly denatured,
and phosphodiester bond is extremely
chemically stable
- Conjugation chemistries for the
attachment of dyes or functional
groups are orthogonal and can be
readily introduced during synthesis

- Pharmacokinetic and other systemic
properties are variable and often hard to
predict
- Small size makes them susceptible to renal
filtration and they therefore have a shorter
half-life
- Unmodified aptamers are highly susceptible
to serum degradation
- Aptamer technologies are currently largely
covered by a single intellectual property
portfolio

Aptamers can be identified for specific targets using a method called systematic
evolution of ligands by exponential enrichment (SELEX). The method was developed in
1990. The SELEX method uses multiple steps to identify aptamer candidates for the
selected target. An oligonucleotide library is used to find multiple candidates that bind to
the target. [25] Typically, the library consists of nucleic acid molecules ranging from 60mers to 96-mers with random sequences and constant primer sequences [26]. The library
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is mixed with an immobilized target, and unbound oligonucleotides are removed. The
bound oligonucleotides are the aptamer candidates. The candidates are removed from the
target and amplified using PCR. These steps are repeated multiple times to identify a
candidate. The aptamer is sequenced so that it can be synthesized for use. Once an
aptamer is sequenced, it can be reproduced in large quantities [25, 27].
The SELEX method has been adapted to work with a wide variety of molecules
making it very useful in areas where other methods, such as using antibodies, are not an
option. Improved variations of the SELEX method allows for discrimination between the
most strongly bound aptamers, and more weakly bound candidates, that would not be
effective for the target. SELEX variations include signaling aptamers which change
structure and produce a signal when bound to the target, and negative SELEX which
removes aptamers that bind to similar molecules first, leaving a smaller, more specific
oligonucleotide pool to select from [25,28,29].
With small molecules like CYN, there are challenges to identifying an aptamer.
SELEX requires the immobilization of the target. Small molecules have inherently less
functional groups than large molecules. These functional groups are used to bind the
target to a stationary phase. Any modification of the target to allow for immobilization
could alter the effectiveness of the aptamer to bind to the original unmodified target.
Small molecules will be in a lower ratio to the column matrix. With an abundance of
column ratio, the chance of non-specific binding aptamer candidates increases. The
binding affinity of the target to the aptamer is a major requirement in determining the
effectiveness of the aptamer. Many methods for determining the binding affinity require
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an obvious change in signal. Methods such as HPLC or capillary electrophoresis require
a difference in size and may be less useful if the target is small because the free aptamer
and the target-aptamer complex may co-elute. Other methods rely on a change in
fluorescence of the target and the target-aptamer complex, but this change in signal
would only occur if the target has fluorescent properties. A fluorescent probe would be
required if the target itself does not have fluorescent properties such as CYN. Though
faced with many challenges, the identification and use of aptamers for small molecules
hold many opportunities for understanding key biological and chemical mechanisms.
Aptamers can detect the presence of small drug molecules, such as cocaine, or biological
molecules such as ATP or intracellular proteins. As an example, a dopamine-specific
aptamer was used to isolate excess dopamine in the brain and determine whether this
removal of dopamine from a part of the brain causes a correction of abnormal brain
activity [30].
Aptamers can also be helpful and effective in detecting the presence of foreign
molecules. Since the development of SELEX and aptamers, there have been hundreds of
aptamers identified. There has been research done on multiple types of targets such as
inorganic components, small organic molecules, antibiotics, and toxins [31] . In fact,
aptamers for multiple cyanotoxins have been studied. The cyanotoxin, microcystin, has
an identified aptamer that is continuing to be studied for various applications [32].
Elshafey et al. identified an aptamer for CYN using SELEX. The authors performed
binding studies using circular dichroism and fluorescence. The binding constant of the
DNA aptamer for CYN was reported as 88.78 nM. Once the binding was established, the
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authors designed an impedimetric aptasensor with the aptamer immobilized on a gold
plate. The change in signal of the sensor was used to detect the presence of CYN in
water samples with known concentrations of CYN and tap water samples spiked with
CYN. The authors reported accuracies of 95.8% to 103.2% [33].
1.4 Circular Dichroism
Light can be circularly polarized wherby the light wave moves in either a
clockwise (right-handed) or counterclockwise (left-handed) direction. These light waves
can be absorbed by a chiral chromophore, or an asymmetrical light-absorbing group.
Circular dichroism (CD) is the difference between the absorbances of the clockwise and
counterclockwise light. The difference is measured using CD spectroscopy. The CD
spectrum of a sample is determined by measuring the differences in absorbance over
multiple wavelengths. The structure of a molecule determines the spectrum so CD
spectroscopy can identify the secondary structures of proteins and DNA. This is
especially helpful in determining a conformational change in DNA when in the presence
of the target molecule [34].
The CD spectroscopy of multiple DNA duplexes and anticancer drugs pairs was
reviewed by Yu-Ming Chang et al [35]. They used the CD data to discuss the
conformational changes of the DNA duplexes observed after exposure to the anticancer
drugs. The conformational change of the DNA is important for improving the anticancer
drugs to make them more target-specific with fewer undesirable reactions [35]. Circular
dichroism spectroscopy was also used to determine the conformational change of the
aptamer for CYN when in the presence of the toxin. In this experiment, CD was used to
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investigate if a conformational change occurs, and what form the DNA takes after the
conformational change [33].
1.5 Fluorescent Biosensing
Fluorescent spectroscopy is a commonly used technique in analyzing organic
compounds. Fluorescent probes can be used to label compounds that do not have
fluorescent properties on their own. Biosensing is the use of DNA, antibodies, or
enzymes to detect the presence of biological or chemical molecules. Fluorescence
biosensing uses changes in fluorescence to determine the presence of a target molecule.
The fluorescence can be from the target molecule’s own fluorescent properties, a
fluorescent label, or a fluorescent probe. Label-free fluorescence biosensing is a
technique that has been studied as a solution to detecting molecules without fluorescent
properties, and without having to label the aptamers or target molecules with a probe, that
would potentially alter their chemical properties [36]. Fluorescent probes are widely
available and some of the probes have greater fluorescence when they bind to aptamers.
Cylindrospermopsin does not have fluorescent properties so a label free method would be
an ideal technique in determining the presence of CYN with the aptamer.
1.6 Aptamer Affinity Chromatography
Aptamer affinity chromatography (AAC) was first reported in 1999 by Drolet et
al. as a means of protein purification [37]. Aptamer affinity chromatography requires the
immobilization of a DNA aptamer to a stationary phase. The aptamer is exposed to the
target molecule in solution and then the target molecule can be separated from the
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aptamer and its original solution. There are many applications of AAC that provide
chromatographic techniques of detection, separation, and purification. Aptamers can be
immobilized on different types of beads such as magnetic beads or streptavidin-modified
beads, and then packed in to a column for analysis. Solid phase extraction can be made
possible with an aptamer that allows for purification of target molecules. Microfluidic
devices have been used to separate and detect target molecules using aptamers. These
techniques can be useful for small molecules, proteins and whole cells. Examples of the
uses of AAC and their targets can be seen in Table 3 [38].
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Table 3. Applications of aptamers in the analysis of the target molecules [38]

Target

Aptamer

Stationary Phase

Application

Adenosine

DNA

Packed capillary column

Detection

ATP

DNA

Hydrogel

Purification

Ochratoxin A

DNA

Resins packed SPE column

Extraction and Offline detection

Cocaine

DNA

Graphene oxide

Extraction and Detection

Arsenic

DNA

Agarose resin

Removal

Thrombin

DNA

Bead-packed column

Purification

Histone proteins

DNA

Bead-packed spin column

Preconcentration

His-tagged proteins

DNA

Magnetic beads

Purification

Thyroid transcription factor 1

DNA

Magnetic beads

Purification

Prostate cancer cells

RNA

Microfluidic device

Capture, enumeration

Glioblastoma

RNA

Microfluidic device

Capture

Salmonella typhimurium

DNA

Magnetic beads

Preconcentration, detection
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1.7 Specific Aims
This study aimed to confirm the binding of the aptamer to CYN. The binding was
investigated using fluorescent biosensing and CD. Since the Elshafey group performed
CD [33], the CD data from this study was performed to compare to the Elshafey CD data
to confirm binding. The fluorescent biosensing was performed to observe a change in
signal indicative of the aptamer binding to the CYN.
The second aim of this study was to determine if the CYN aptamer could have a
real world application in the form of an aptamer affinity capture method. Magnetic beads
were used to immobilize the aptamer for incubation with CYN. High performance liquid
chromatography was used to determine if the CYN bound to the beads and if CYN could
be eluted off he beads.
2. Materials
2.1 Purification of CYN
The algal cultures used in the purification of CYN were grown by Dr. Gantar’s
lab at FIU. The algal cultures were grown in BG-11 medium, modified from Rippka et al
[39]. The pH of the medium was adjusted to 7.0 with NaOH. The medium was
autoclaved at 121ºC for 15 min before use. The pH was further adjusted to 7.4 using
NaOH after autoclaving. The BG-11 medium used for the growing cycles was run
through a 0.22 µm Millipore syringe filter. The cultures were grown under a 40W neon
lamp for 24 h. An incubation temperature of 27-30ºC was used for the growing cycles
[39].
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HPLC-grade water and acetonitrile were purchased from Fisher Scientific
(Thermo Fisher Scientific, Fair Lawn, NJ). HPLC-grade methanol was purchased from
EMD Millipore Corporation (Billerica, MA). Formic acid was purchased from Fluka
Analytical Sigma-Aldrich (Chemie Gmbh, Steinhein, Germany). Trifluoroacetic acid
was purchased from J.T. Baker, Mallinckrodt Baker Inc. (Phillipsburg, NJ). Chitosan
was purchased from Sigma Aldrich (St. Louis, MO). A WaterPro PS Milli-Q® water
system (Labconco, Kansas City, MO) was used to obtain the Milli-Q® water used in the
purification. The filters used were Millipore Nitrocellular MFTM 0.45um HA, 47mm,
non-sterile filter and Millipore Nylon Membrane 0.20um, 47mm, non-sterile filter
purchased from Merck Millipore Ltd. (Tullagreen, Cork, Ireland). The SPE cartridge
used was ExtractClean™ Carbo 300mg/8mL purchased from Grace Davidson Discovery
Science (Deerfield, IL). Falcon™ 50mL conical centrifuge tubes, HPLC vials (2.0 mL,
amber), and scintillation vials (20 mL, borosilicate glass) were purchased from Fisher
Scientific (Thermo Fisher Scientific, Fair Lawn, NJ).
2.2 Fluorescent Biosensing
The CYN purified in 3.1 and a CYN standard (1 mg) purchased from Enzo Life
Sciences (Farmingdale, NY) was used for this experiment. L-BMAA hydrochloride and
microcystin-LR standards were purchased from Sigma Aldrich (St. Louis, MO). The
binding buffer was made with 50 mM Tris, pH 7.5, 20 mM MgCl 2 and 150 mM NaCl.
The TRIZMA® hydrochloride reagent grade (Tris) and NaCl was purchased from Sigma
Lifescience (Sigma-Aldrich, St Louis, MO). The MgCl2 6 hydrate crystal was purchased
from J.T. Baker (Mallinckrodt Baker Inc., Phillipsburg, NJ) [33] The DNA aptamer (5’
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amino modification, 6 carbon linker, HPLC purified) was purchased from Integrated
DNA Technologies (IDT)(Coralville, IA) using the DNA sequence from Elshafey et al.
[33]. The fluorescent probes Quantifluor double strand and single strand were purchased
from Promega (Madison, WI). The probes SYBR Gold, SYBR Green, and Oligreen were
purchased from Invitrogen (Thermo Fisher Scientific, Carlsbad, CA). A 10 mm quartz
cuvette was used for measurements as discussed in 3.2.
2.3 Circular Dichroism
The CYN purified in 3.1 was used for this experiment. The BB used in 2.2 was
also used in this experiment [33]. The DNA aptamer (5’ amino modification, 6 carbon
linker, desalted) was purchased from Integrated DNA Technologies (IDT)(Coralville, IA)
using the DNA sequence from Elshafey et al. [33]. A 10 mm quartz cuvette was used for
measurements as discussed in 3.3.
2.4 Aptamer Affinity Capture
The Dynabeads M-270 Carboxylic Acid magnetic beads were purchased from
Invitrogen (Thermo Fisher Scientific, Carlsbad, CA). The BB used in 2.2 was also used
in this experiment. The EDC and MES buffer for activation were purchased from Sigma
Lifescience (Sigma-Aldrich, St Louis, MO). The DNA aptamer (5’ amino modification, 6

carbon linker, HPLC purified) was purchased from Integrated DNA Technologies
(IDT)(Coralville, IA) using the DNA sequence from Elshafey et al. [33]. The CYN
standard (1 mg) was purchased from Enzo Life Sciences (Farmingdale, NY). A
WaterPro PS Milli-Q® water system (Labconco, Kansas City, MO) was used to obtain
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the Milli-Q® water used in this experiement. The magnet used was a Neodymium
rectangular block magnet. EppendorfTM Microcentrifuge tubes were purchased from
Fisher Scientific (Fair Lawn, NJ).
2.5 Urea PAGE Gel
The urea, APS, TEMED, and acrylamide (40% w/v) were purchased from Fisher
Scientific (Thermo Fisher Scientific, Fair Lawn, NJ). The 5X TBE buffer consisted of
445 mM Tris base, 445 mM boric acid and 10 mM EDTA, all purchased from Fisher
Scientific (Thermo Fisher Scientific, Fair Lawn, NJ). The DNA aptamer (5’ amino
modification, 6 carbon linker, HPLC purified) was purchased from Integrated DNA
Technologies (IDT)(Coralville, IA) using the DNA sequence from Elshafey et al. [33].
The DNA ladder consisted of DNA fragments (11, 14,17, 20, 23, 26, 29, 32, 35, 38 nt)
purchased from Integrated DNA Technologies (IDT)(Coralville, IA). The fluorescent
probes Quantifluor double strand was purchased from Promega (Madison, WI). The
CYN standard (1 mg) was purchased from Enzo Life Sciences (Farmingdale, NY). LBMAA hydrochloride and microcystin-LR standards were purchased from Sigma Aldrich
(St. Louis, MO). Xylene cyanol FF (Sigma Lifescience Sigma-Aldrich, St Louis, MO).
3. Experimental
3.1 Purification of CYN
The culture was prepared and purified used a method that was previously
modified [40-42]. The method is briefly described below.
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3.1.1 Pretreatment of Culture Medium and Biomass
The culture was transferred to four 500 mL centrifuge bottles; each bottle
contained 300 mLs of the culture. Chitosan was added at a volume of 10 mL to each
bottle. The bottles were centrifuged for 20 min at 4000 rpm using a Beckman Coulter
Allegra X-15R centrifuge. The clarified culture medium (supernatant) was poured off,
leaving around 20 mL of supernatant at the bottom of the bottle, in to multiple 1 liter
bottles, and refrigerated for later use. The remaining volume of supernatant left in the
bottle was used to resuspend the biomass layer on the bottom of the bottle. The contents
of the bottle were then transferred to several 50 mL falcon tubes. Chitosan was added at
a volume of 2 mL to each tube. The tubes were centrifuged with the same parameters
described above. The medium was transferred into the 1L bottles (with previously
collected culture medium) and the biomass in the tubes was immediately frozen at -20ºC.
Once frozen, the biomass was lyophilized in the falcon tubes using a Labconco Freezone
Cascade Benchtop Freeze Dry System, and kept in -20ºC for later use.
3.1.2 Extraction of CYN from Culture Biomass
The lyophilized biomass was weighed out to 2.0 g, and re-suspended in 200 mL
of Milli-Q® water in a 500 mL Erlenmeyer flask. The solution was left to sit for 24 h to
allow for full resuspension of the cells. The solution was then transferred to two 200 mL
Erlenmeyer flasks with 100 mL of Milli-Q® water in each flask. The two flasks were
then sonicated in an ultrasonic bath for two 5 min periods. The flasks were swirled in
between each 5 min period. The biomass was then filtered in a vacuum filtration
apparatus using a 0.45 micrometer membrane filter. When the biomass was filtered, 5
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mL of Milli-Q® water was put through the filter to rinse the filter apparatus. The filtrate
was then filtered using a 0.20 micrometer membrane filter. The apparatus was rinsed
with another 5 mL of Milli-Q® water. The filtrate was transferred to a carbograph SPE
cartridge and filtered using a vacuum manifold. The cartridge was pretreated with 3.0
mL of 5% FA in MeOH followed by 3.0 mL of Milli-Q® water. After the filtrate had
passed through the cartridge, it was washed with 0.5 mL of methanol. Following the
washing step, 20 mL of 5% FA in MeOH was run through the cartridge, as the eluent,
and collected in a scintillation vial. The eluent was dried down using a rotating
evaporator and the sample was re-suspended in 250 µL of Milli-Q® water. The sample
was then stored in 4ºC in a 2.0 mL glass vial until analysis.
3.1.3 Extraction of CYN from Culture Medium
The previously prepared (i.e., centrifuged) culture medium was transferred in to
500 mL centrifuge bottles and centrifuged at 4000 rpm for 20 min. The supernatant was
subsequently filtered by vacuum through a 0.2 µm membrane filter. The filtrate was
passed through a carbograph SPE cartridge and filtered using a vacuum manifold. The
cartridge was pretreated with 3.0 mL of 5% FA in MeOH followed by 3.0 mL of MilliQ® water. After the filtrate had passed through the cartridge, it was washed with 0.5 mL
of methanol. Following the washing step, 20 mL of 5% FA in MeOH was run through
the cartridge, as the eluent, and collected in a scintillation vial. The eluent was dried
down using a Buchi R-3 rotating evaporator and the sample was re-suspended in 250 µL
of Milli-Q® water. The sample was then stored in 4ºC in a 2.0 mL glass vial until
analysis.
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3.1.4 HPLC Purification
Final purification and analysis of CYN was performed on a Shimadzu
Prominence modular UFLC. A Luna 5u C18 100A, 250 x 4.60 mm, 5 micron column
was used. The injection volume of the sample was 10 µL and the sample was monitored
at 262 nm. The mobile phase consisted of 0.1% TFA in HPLC water (A) and 0.1% TFA
in ACN (B). The flow rate was 1 mL/minute. The gradient method is listed in Table 4.
The chromatograph and UV spectrum was monitored to observe the peak with the UV
spectrum that corresponds with CYN. The mobile phase exiting the HPLC (fraction) is
collected in a scintillation vial immediately after the CYN peak is observed. The sample
run is repeated until the medium or biomass sample is completely utilized. The fractions
are collected in the same scintillation vial. The fractions were dried using the rotating
evaporator to obtain solid CYN material.
Table 4. Time program for HPLC purification of CYN
Time (min)

% of Solvent A

% of Solvent B

0 – 30

100-92

0-8

30 – 32

92-100

8-0

32 – 35

100

0
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3.2 Fluorescent Biosensing
3.2.1 Fluorimeter
Control samples of binding buffer, 1X SYBR Green, 10 uM aptamer and 100 µM
CYN were run to determine if the samples contributed a fluorescent signal. The probe
was added to the aptamer, with final concentrations of 1X and 10 uM, respectively. The
sample was analyzed to obtain a baseline of the fluorescent signal. The CYN was added
to samples of the SYBR Green and the aptamer at varying final concentrations (10 µM,
25 µM, 50 µM, 75 µM, 100 uM, 350 uM, and 500 uM). All samples had a final volume
of 1.2 mL.
The Horiba Fluoromax-3 fluorimeter was used to measure the fluorescent signal
of the samples. The emission was set to scan from 500 to 650 nm and the excitation was
set to 497 nm. The signal was averaged from a total of three scans set at the fast scan
mode. A quartz cuvette with a 10 mm path length was used to measure the fluorescence.
3.2.2 Tecan Plate Reader
A super mix was made consisting of a 1.1X mixture of the DNA aptamer and BB.
A 1.05X ultra mix of fluorescent probe (SYBR Gold, SYBR Green, Oligreen,
QuantiFluor double strand or QuantiFluor single strand) and the super mix was created.
An aliquot of the ultra mix was added to 100 µM of the target (CYN, MC-LR, or BMAA)
at a final volume of 100 µL for the Tecan sample. The final concentration in the sample
was 1X fluorescent probe, 1 µM DNA aptamer and 100 µM target. The sample was
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transferred in to the plate with 95 µL of sample in each well. A control sample of
aptamer, fluorescent probe, and BB was run with the samples.
The Tecan Infinite M1000 Pro was used to expand on the fluorimeter data using
different probes with smaller volumes. The samples were analyzed first to obtain the
gain and Z position calculated from the control sample. The excitation and emission
values were set according the fluorescent probe in the sample. The samples were then
analyzed with a manually entered gain and Z position of each fluorescent probe from the
first analysis. The percent gain was calculated from the results of the samples compared
to the results of the control.
3.3 Circular Dichroism
All samples were prepared in binding buffer with final volumes of 1.2 mL.
Samples of binding buffer and 2 uM CYN were used to obtain background signals.
Spectrum of a 1 uM sample of the aptamer was measured and compared to the spectrum
of a 1 uM of the aptamer after addition of 2 uM CYN. Samples were analyzed in a quartz
cuvette with a 10 mm path length.
A Jasco J-815 Circular Dichroism Spectrometer was used to measure the
structural conformation of the samples. The measurements were made from 230 to 340
nm at a 0.1 nm interval. Three scans were performed at 20 nm/min with a 1 nm
bandwidth and a 1 sec time constant. Nitrogen was used to deoxygenate the optical
chamber and was maintained throughout the duration of the experiment.
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3.4 Aptamer Affinity Capture
3.4.1 Magnetic Bead Activation
Magnetic beads (Dynabeads) were used as the solid phase for AAC. The beads
were activated following a modified Thermo Scientific protocol. A volume of 100 uL of
the beads was transferred to an Eppendorf tube. A magnet was applied for two minutes
and the supernatant was removed. The beads were washed with 100 uL of 25 mM MES
buffer, pH 5, for 10 min on a Stuart SB3 rotator. The magnet was applied to the tube for
two minutes and the supernatant was removed. The wash was repeated once more. In a
separate Eppendorf tube a 60 uL solution was made with MES buffer and the DNA
aptamer with final concentrations of 25 mM and 2 mg/mL, respectively. The solution
was added to the beads and incubated on the rotator for 30 minutes. A 30 uL solution of
100 mg/mL EDC was made immediately before use in cold 100 mM MES buffer. The
solution was mixed with the beads and then 10 uL of 25 mM MES buffer was added for a
final volume of 100 uL. The beads were incubated at 4ºC overnight on the rotator. After
the incubation, the beads were washed with 50 mM Tris buffer for 15 minutes at room
temperature. The magnet was applied for two minutes and the supernatant was removed.
The wash was repeated three more times. The beads were resuspended in binding buffer
and stored at 4ºC until use. Control beads were made following the same procedure
without the addition of the DNA aptamer. The 60 uL solution was made with MES
buffer and Milli-Q® water.
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3.4.2 CYN Capture
The beads were washed with binding buffer for 15 minutes three times. A 100 uL
sample of 75 µM CYN was added to the beads and was incubated for 2 h on the rotator at
room temperature. The magnet was applied for two minutes. The supernatant was
removed and placed in a 2 mL HPLC vial for analysis. Milli-Q® water was then added
to the beads at a volume of 200 µL. The beads were mixed for 12 h on the rotator at
room temperature. The magnet was applied for two minutes and the supernatant was
placed in a 2 mL HPLC vial for analysis. The beads were washed three times as
previously mentioned and the procedure was repeated with the 100 µM and 150 µM
CYN samples.
3.4.3 HPLC of AAC Samples
Each concentration of CYN produced three samples for HPLC after incubation
with the beads. The sample collected after the addition of CYN, the sample collected
after the elution with Milli-Q® water and the wash sample were analyzed to determine
the percent recovery of CYN. The analysis was performed on a Shimadzu HPLC. A
Kinetex 2,6u C18 100A, 100 x 4.6 mm column was used for analysis. The injection
volume of the sample was 20 µL and the sample was monitored at 262 nm. The mobile
phase consisted of HPLC water (A) and acetonitrile (B). The flow rate was 0.27
mL/minute. The gradient method is listed in Table 5.
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Table 5. Time program for detection of CYN
Time (min)

% Solvent A

% Solvent B

0-15

98-90

2-10

15-18

90-98

10-2

18-20

98

2

3.5 Urea PAGE Gel
3.5.1 Gel Preparation
The gel was prepared by mixing 10.5 g of urea, 5 mL of 5X TBE buffer (445mM
Tris base, 445mM Boric acid, 10mM EDTA) and 9.4 mL 40% (w/v) acrylamide. The
solution was stirred using a magnetic stir bar until the urea dissolved. Once the urea
dissolved, 139 µL of 10% (w/v) APS and 13.2 µL of TEMED was added to the solution.
The solution was then quickly poured between the gel plates and the well comb was
placed. The gel was left to polymerize for 30 min.
3.5.2 Gel Samples
The samples analyzed with the Tecan plate reader were used for the gel. The
samples were made with 5 µL of the fluorescence sample and 10 µL of the gel loading
dye. The DNA ladder did not contain a length up to 62 bases, which is the length of the
DNA aptamer so 1 µL of 1 µM DNA aptamer was added to the ladder sample.
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3.5.3 Running and Imaging the Gel
The gel was set up in the gel apparatus and was pre-run for an hour to remove any
molecules in the gel. The gel was loaded with 3 µL of each sample. Once the samples
were loaded, the gel was run for 3.5 hours. The gel was removed from the gel plates and
was placed in a container with a stain mixture of TBE buffer and SYBR gold. The gel
was agitated in the stain every 5 min for 25 min. The gel was cleaned with ethanol and
imaged using a Bio-Rad ChemiDoc system.
4. Results and Discussion
4.1 Fluorescent Biosensing

Figure 2. Fluorescent spectrum of (A) Binding buffer (BB), (B) CYN in BB, (C) Aptamer
in BB, (D) Aptamer in BB (top) 100 uM CYN and Aptamer in BB (middle) and 500 uM
CYN and Aptamer in BB (bottom)
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25 uM
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Figure 3. Fluorescence spectrum of Aptamer in BB and after the addition of 10 uM CYN
(10 uM), 25 uM CYN (25 uM), 50 uM CYN (50 uM), 75 uM CYN (75 uM), and 100 uM
CYN (100 uM).

MC-LR
BMAA

CYN

Figure 4. Fluorescent spectrum of aptamer after the addition 100 uM Microcystin-LR
(MC-LR), 100 uM BMAA (BMAA), and 100 uM CYN (CYN)
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Figure 5. Percent gain of CYN with five different fluorescent probes
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Figure 6. Percent Gain of CYN using QuantiFluor dsDNA probe
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Figure 7. Reproducibility of Percent Gain of CYN using QuantiFluor dsDNA probe
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Figure 8. Reproducibility of Percent Gain of MC-LR using QuantiFluor dsDNA probe
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Reproducibility BMAA
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Figure 9. Reproducibility of Percent Gain of BMAA using QuantiFluor dsDNA probe
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Figure 10. Comparison of Percent Gain of the three toxins with QuantiFluor dsDNA
probe
The fluorescence spectrum of the multiple concentrations of CYN (Figure 2D and
3) shows a decrease in signal as the concentration of CYN increases. The decrease in
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signal suggests that the CYN is binding to the aptamer and causing the release of the
fluorescent dye from the aptamer. The spectrum of the aptamer with different toxins
(Figure 4) shows a decrease in signal. The desired result would have been for a decrease
in signal to only occur in the presence of CYN. The results suggest that the specificity of
the aptamer is not as high as previously reported in Elshafey et al. [33]. Elshafey et al.
tested for change in electrochemical signal with MC-LR and another cyanotoxin,
anatoxin. The paper reported no obvious change in signal with MC-LR. The aptamer
was exposed to BMAA to test another toxin that has been detected in similar
environments as CYN. This toxin exhibited a larger change in signal than MC-LR but a
smaller change in signal than CYN. This suggests that BMAA binds to the aptamer
stronger than MC-LR but has a weaker affinity than CYN. The five fluorescent probes
were tested to determine which probe resulted in the largest change in signal (percent
gain) as shown in Figure 5. The QuantiFluor dsDNA provided the largest change in
signal when analyzing the control sample in comparison to the sample with CYN added
to the aptamer. The QuantiFluor dsDNA was tested to determine if the probe gave
consistent results. The QuantiFluor dsDNA data in Figure 6 provided consistent results
for percent gain. The data have an average 71.28% and a standard deviation of 0.98. The
QuantiFluor dsDNA probe was then used for all other fluorescence samples. The five
CYN samples in Figure 7 were analyzed after 30 min of incubation to determine if the
samples were reproducible. The percent gain of CYN had an average of 68.55% and a
standard deviation of 2.5. The change in signal suggests that CYN is binding with the
aptamer causing the release of the probe at a high rate. There was a 68.55% change in
signal in only 30 min. The samples of MC-LR in Figure 8 were analyzed after a 30 min
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incubation. The average percent gain was 31.2% with a standard deviation of 1.9.
Although the change is relatively small, any change in signal conflicts the original report
of Elshafey et al. that reports no obvious change in electrochemical signal with the
aptamer incubated with MC-LR. The change in fluorescent signal was observed in both
the data from the fluorimeter as well as the Tecan data in Figure 8. The BMAA samples
in Figure 9 were analyzed after a 30 min incubation. The average gain was 56.72% with
a standard deviation 5.3. Although the standard deviation of the samples was high, the
large signal change suggests binding. The paper by Elshafey et al. did not test BMAA for
an electrochemical signal change. The large signal change suggests that the aptamer is
not specific for CYN. The comparison of the percent gain of the three toxins in Figure 10
shows that percent gain of the BMAA is similar to that of the CYN. The MC-LR sample
percent gain though much lower is still an obvious change.
4.2 Circular Dichroism
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Figure 11. CD spectrum of (A) 1 uM aptamer before and after the addition of 2 uM CYN
performed by Elshafey et al. [33] and (B) 1 uM aptamer before and after the addition of 2
uM CYN
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The CD spectra in Figure 11B is very similar to the one performed by Elshafey et
al. (Figure 11A). The two spectra suggest the aptamer forms a B-DNA duplex. The BDNA duplex has a characteristic positive band at 278.5 nm and a negative band at 248
nm. A decrease in ellipticity when CYN was added suggests that a conformational
change occurs.
4.3 Aptamer Affinity Capture

A

B

0
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D

Figure 12. Chromatogram of (A) supernatent after incubation with beads, (B) 75 uM
CYN standard, (C) supernatant after elution with Milli-Q® water, (D) supernatant after
wash with BB

The peak at 8.29 minutes in Figure 12A displays the presence of CYN in the
supernatant after the addition of CYN. The peak suggests that all the CYN in the
addition sample did not bind to the aptamer that was bound to the beads. There is no
peak in Figure 12C after the elution step suggesting that the CYN that was bound to the
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aptamer did not elute and is still bound to the aptamer. The CYN could be bound tightly
to the aptamer as the binding constant of 88.78 nM reported by Elshafey et al. suggests a
high affinity for CYN. The absence of a peak in Figure 12C can also be explained if the
amount of CYN that was bound to the aptamer was eluted but the concentration was too
long for detection on the HPLC. Cylindrospermopsin has been shown to be genotoxic
and cause DNA breakage [44]. The CYN concentration could be at a level that causes
minor DNA breakage. The breakage could explain the appearance of a peak in the
supernatant sample after the addition of 75 uM CYN. If the CYN was degrading the
DNA then some of the CYN would be in the addition sample because the DNA would
break at the binding site of CYN. The intact DNA would bind to a percentage of CYN
and the rest of the CYN sample would come out in the supernatant. The possibility of the
aptamer degrading in the presence of CYN was then investigated. Another explanation
for the peak in the supernatant fraction would be that there was an overabundance of
CYN in relation to the aptamer or free binding sites on the aptamer. There would be an
excess of CYN which would be removed in the supernatant fraction.

33

4.4 Urea PAGE Gel

Figure 13. (A) Urea PAGE Gel of DNA ladder (1), Aptamer (2), Aptamer and CYN (3),
Aptamer and MC-LR (4), Aptamer and BMAA (5), and DNA Ladder (6), (B) inverse of
gel (A)
The gel in Figure 13 shows that there are no additional bands in any of the
samples with toxin. Since the samples do not show degradation of DNA which means
degradation is not the cause of the AAC not working.
5. Conclusions
The health risk that cylindrospermopsin poses to humans and their food chains
makes the identification and utilization of an aptamer an important topic to study.
Aptamers are an emerging tool and have been proven to be of use for small molecules.
The cost effectiveness of aptamers and the specificity that aptamers offer make them a
great option for the detection of cyanotoxins. Contamination of water supplies can be
determined with minimal cost and greater accuracy. The studies on an aptamer for CYN
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need to be investigated further to optimize binding and determine the applications of
AAC for CYN.
The fluorescent binding studies and CD performed in this work showed that CYN
does bind to the aptamer as reported in the Elshafey et al. paper. The CD from the paper
was reproducible and confirmed a B-DNA complex of the aptamer. The fluorescent
binding studies confirmed the author’s conclusion that CYN binds to the aptamer. The
fluorescence data showed that a change in gain occurred for both the MC-LR and
BMAA. The author tested MC-LR and reported no obvious change in the
electrochemical signal. The fluorescent data for MC-LR showed a small but significant
signal change. The results for BMAA showed a large signal change that was similar to
CYN. The authors did not test for BMAA, which is a much smaller toxin. The small
size may play a role in its ability to bind to the aptamer since CYN is a smaller molecule
as well. The binding of BMAA and the aptamer should be further investigated to
determine if the aptamer has a strong affinity for BMAA as well as CYN. The aptamer
should also be tested with other toxins to determine if there is a functional group or type
of toxins that the aptamer binds to. This would help differentiate which functional
groups on the toxins bind to the aptamer.
The HPLC data for the aptamer affinity capture showed that the CYN may have
bound to the aptamer on the beads. There are multiple explanations for the absence of a
CYN peak in the elution sample. The CYN may not have been eluted and are still bound
to the beads. The CYN could have eluted off the beads but at a low concentration the
CYN may not have been detected by the HPLC. The urea PAGE gel proved the
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unbound CYN in the addition sample fraction was not an effect of DNA degradation by
CYN.
A new aptamer should be investigated as well since the fluorescent data showed
that the aptamer identified in Elshafey et al. may not be specific for CYN. The aptamer
reported in the Elshafey et al paper is an option for aptamer affinity capture but the use of
the aptamer for detection or purification in an aptamer affinity chromatography method
needs to be investigated further to determine the proper eluent to remove the CYN from
the beads. An aptamer affinity chromatography method for CYN could greatly benefit
the areas in which CYN blooms form. The ability to quickly and accurately detect CYN
contamination in water supplies could protect a large quantity of people and their food
sources.
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